These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25354444)

  • 21. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.
    Tang D; Shen Y; Wang M; Yang R; Wang Z; Sui A; Jiao W; Wang Y
    Eur J Cancer Prev; 2013 Nov; 22(6):540-8. PubMed ID: 23462458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy.
    Cheng G
    Adv Drug Deliv Rev; 2015 Jan; 81():75-93. PubMed ID: 25220354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs: novel therapeutic targets in neurodegenerative diseases.
    Roshan R; Ghosh T; Scaria V; Pillai B
    Drug Discov Today; 2009 Dec; 14(23-24):1123-9. PubMed ID: 19822222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies.
    Sheinerman KS; Umansky SR
    Front Cell Neurosci; 2013 Sep; 7():150. PubMed ID: 24058335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating miRNA profiling to identify biomarkers of dysmetabolism.
    Tomaselli S; Panera N; Gallo A; Alisi A
    Biomark Med; 2012 Dec; 6(6):729-42. PubMed ID: 23227838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
    Zandberga E; Kozirovskis V; Ābols A; Andrējeva D; Purkalne G; Linē A
    Genes Chromosomes Cancer; 2013 Apr; 52(4):356-69. PubMed ID: 23404859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating microRNAs: emerging biomarkers for diagnosis and prognosis in patients with gastrointestinal cancers.
    Lindner K; Haier J; Wang Z; Watson DI; Hussey DJ; Hummel R
    Clin Sci (Lond); 2015 Jan; 128(1):1-15. PubMed ID: 25168167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers of neurodegenerative disorders: how good are they?
    Rachakonda V; Pan TH; LE WD
    Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of DNA microarray-based high throughput gene analysis system for molecular diagnosis].
    Takahashi Y; Goto J; Tsuji S
    Tanpakushitsu Kakusan Koso; 2005 Dec; 50(16 Suppl):2115-21. PubMed ID: 16411439
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnostic microRNA markers to screen for sporadic human colon cancer in blood.
    Ahmed FE; Amed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Allison RR
    Cancer Genomics Proteomics; 2012; 9(4):179-92. PubMed ID: 22798503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systems approach to neurodegenerative disease biomarker discovery.
    Lausted C; Lee I; Zhou Y; Qin S; Sung J; Price ND; Hood L; Wang K
    Annu Rev Pharmacol Toxicol; 2014; 54():457-81. PubMed ID: 24160693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating miR-18a: a sensitive cancer screening biomarker in human cancer.
    Komatsu S; Ichikawa D; Takeshita H; Morimura R; Hirajima S; Tsujiura M; Kawaguchi T; Miyamae M; Nagata H; Konishi H; Shiozaki A; Otsuji E
    In Vivo; 2014; 28(3):293-7. PubMed ID: 24815829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
    Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.
    Powrózek T; Krawczyk P; Kowalski DM; Winiarczyk K; Olszyna-Serementa M; Milanowski J
    Transl Res; 2015 Oct; 166(4):315-23. PubMed ID: 26079400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of novel genomic blood biomarkers for neurodegenerative diseases.
    Borovecki F; Habek M
    CNS Neurol Disord Drug Targets; 2010 Dec; 9(6):669-78. PubMed ID: 20942794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating microRNAs: emerging biomarkers of liver disease.
    Arrese M; Eguchi A; Feldstein AE
    Semin Liver Dis; 2015 Feb; 35(1):43-54. PubMed ID: 25632934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A panel of five circulating microRNAs as potential biomarkers for prostate cancer.
    Chen ZH; Zhang GL; Li HR; Luo JD; Li ZX; Chen GM; Yang J
    Prostate; 2012 Sep; 72(13):1443-52. PubMed ID: 22298030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different normalization strategies might cause inconsistent variation in circulating microRNAs in patients with hepatocellular carcinoma.
    Tang G; Shen X; Lv K; Wu Y; Bi J; Shen Q
    Med Sci Monit; 2015 Feb; 21():617-24. PubMed ID: 25719241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating microRNAs in the cerebrospinal fluid of patients with brain diseases.
    Machida A; Ohkubo T; Yokota T
    Methods Mol Biol; 2013; 1024():203-9. PubMed ID: 23719953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical proteomics in neurodegenerative disorders.
    Zetterberg H; Rüetschi U; Portelius E; Brinkmalm G; Andreasson U; Blennow K; Brinkmalm A
    Acta Neurol Scand; 2008 Jul; 118(1):1-11. PubMed ID: 18279484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.